Home > Quotes > PSTI > Company News

Pluristem Therapeutics, Inc. News Headlines

PSTI 
$3.06
*  
0.06
  negative  
2%
Get PSTI Alerts
*Delayed - data as of May 21, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PSTI Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013
5/20/2013 11:38:00 AM - Seeking Alpha

Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert
5/13/2013 7:08:00 AM - Seeking Alpha

United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
4/30/2013 4:19:00 AM - Seeking Alpha

Pluristem Says Research Demonstrates PLX-PAD Cells' Safety In PAH Treatment
4/29/2013 4:23:00 AM - RTT News

An Industry Outlook With Analyst Vernon Bernardino
4/22/2013 5:30:00 AM - Seeking Alpha

PSTI Plans to Start Phase I Study - Analyst Blog
4/19/2013 4:11:14 PM - Zacks.com

Investing In The Stem Cell Sector: An Overview
4/17/2013 8:36:00 AM - Seeking Alpha

UTHR to Move PAH Drug into Phase I - Analyst Blog
4/15/2013 12:11:40 PM - Zacks.com

United Therapeutics Gets Nod For Early-stage Study Of Pluristem's PLX-PAD Cells
4/11/2013 3:38:00 AM - RTT News

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
4/10/2013 4:00:00 AM - Seeking Alpha

Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy
3/28/2013 9:14:00 AM - Seeking Alpha

Pipeline Progress at Pluristem - Analyst Blog
3/25/2013 6:31:03 PM - Zacks.com

The Future Of Medicine: A Look At 5 Stem Cell Companies
3/22/2013 11:58:00 AM - Seeking Alpha

Phase II Trials Will Be Pivotal For These Stem Cell Companies
3/20/2013 3:26:00 AM - Seeking Alpha

The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert
3/15/2013 11:20:00 AM - Seeking Alpha

Pluristem & UTHR Progress with PLX-PAD - Analyst Blog
3/4/2013 6:25:01 PM - Zacks.com

2012 Stem Cell Standouts And The Outlook For 2013
2/28/2013 2:15:00 PM - Seeking Alpha

New Orphan Drug Designation For Pluristem Could Gain Access To FDA 'Progressive Approval'
2/27/2013 5:25:00 AM - Seeking Alpha

3 Regenerative Medicine Companies That Could Deliver In 2013
1/22/2013 9:33:00 AM - Seeking Alpha

Pluristem Progresses with New Facility - Analyst Blog
1/4/2013 7:27:01 PM - Zacks.com

Stem Cells, Dr. Oz And A Potentially Lucrative Investment Opportunity
1/2/2013 4:37:00 PM - Seeking Alpha

Formation Of A New Expert Group Moves Pluristem Into The Expansive Hematology Field
12/5/2012 6:59:00 PM - Seeking Alpha

Maxim Group Highlights 3 Stem Cells Stocks To Consider And 1 To Avoid
12/4/2012 10:03:00 AM - Seeking Alpha

Orphan Status Update from Pluristem - Analyst Blog
11/27/2012 7:00:01 PM - Zacks.com

4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce
11/20/2012 9:58:00 AM - Seeking Alpha